Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: Frank Stein who wrote (167)	3/20/1998 8:11:00 PM
From: Wesley Turnblot	Read Replies (1) \| Respond to of 579

Frank, You need to separate pathology from neurology. Though it is estimated to take well over a decade from first pathology to ultimate loss of all cognitive capacity - when during this time do you see the neurology? How many neurons die until a person is noticeably demented? Swift progression = the passage of time after a person is first diagnosed up to the time point when cognition is no longer enhanceable. <<less than 4 years in the majority of cases>> maybe through your high school you can arrange to volunteer at a clinic/ adult home and see what AD means for a person vs. for a brain/ brain cell. You need to be more thoughtful and objective: we are here to make money - ANY INTERVENTION TO PREVENT NEURODEGENERATION NO MATTER HOW NON-SPECIFIC WILL BE EXTREMELY PROFITABLE. (Though I am more intellectually motivated by understanding mechanism and mechanistic approach to disease prevention.) And yes, Mattson isn't even approaching mechanism - maybe if you understood his work you would have followed this in my post. Wes